RocheCanada.com English

FIRST AND ONLY PERSONALIZED TREATMENT FOR DEADLIEST FORM OF SKIN CANCER APPROVED BY HEALTH CANADA

New Hope Ahead for Children Suffering with Rare Childhood Disease

Roche enters strategic alliance with Technoclone to expand reagent portfolio for coagulation diagnostics line targeted for US and Canada in 2014.

Roche announces positive results of pivotal Phase III study with pertuzumab in HER2-positive metastatic breast cancer

Roche acquires Verum Diagnostica GmbH as part of plan to develop comprehensive coagulation testing portfolio for diagnostic laboratories

Health Canada approves the cobas® 4800 BRAF V600 Mutation Test, the first Roche companion diagnostic developed with a drug

Roche to expand coagulation testing portfolio, develop new systems for diagnostic laboratories in US and Canada by 2014

Roche Canada Supports University of British Columbia

Roche makes significant investment to establish a global site for Pharmaceutical Development in Canada

Roche Diagnostics launches its new blood gas analyzer

Roche Diagnostics launches the cobas® 8000 modular analyzer series in Canada at BC Biomedical Laboratories.

Roche Diagnostics Canada launches Accu-Chek^®Mobile, the world’s first strip-free blood glucose monitoring device

Pivotal Study Validates Roche’s cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer

New automated regional lab means better efficiency and increased patient safety

Roche Diagnostics launches new assays for early detection of  Preeclampsia, a serious pregnancy complication. A first in Canada!

Health Canada approves HERCEPTIN® for patients with HER2-positive advanced stomach cancer

A New Study Shows that Testing for Human Papillomavirus Genotypes 16 and 18 Detects Cervical Pre-Cancer Missed by Pap Test

Roche Diagnostics launches post-analytical workflow solution for high volume labs

Roche Introduces New Health Canada Approved Automated Clinical Laboratory System for Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae

The CHUS biochemistry and hematology laboratories acquire state of the art technology (in order to provide) enabling faster, safer services

Health Canada Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C

ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone

Landmark Genotyping Study Demonstrates the Power of 454 Sequencing Systems for Immunogenetics

“Rex by Your Side”

Roche Diagnostics Distributes TheraScreen®: K-RAS Mutation Kit

Test aids physicians to identify colorectal cancer patients who are unlikely to benefit from certain cancer drugs based on their genetic mutations

Northern Health launches new analyzers and laboratory solution

Launch of large study on vascular events in noncardiac surgery patients - prospective study to find previously undetected myocardial infarctions through troponin testing

Battlefords Union Hospital goes live with the Cobas 6000 Chemistry Analyzer

The Mont Blanc Ascent and organ donation from living donors - Two challenges to out do oneself

Even easier to use

The new Accu-Chek Compact Plus with all-in-one convenience

AHSC’s Medical Laboratory at the Saint John Regional Hospital becomes first fully operational, automated and integrated laboratory in the Maritimes